— Know what they know.
Not Investment Advice
Also trades as: DRREDDY.NS (NSE) · $vol 25M · DRREDDY.BO (BSE) · $vol 1M

RDY NYSE

Dr. Reddy's Laboratories Limited
1W: +0.1% 1M: +0.7% 3M: -14.6% YTD: -11.5% 1Y: -13.7% 3Y: -5.8% 5Y: -3.4%
$12.25
+0.00 (+0.00%)
 
Weekly Expected Move ±4.2%
$11 $12 $12 $13 $13
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 59 · $10.2B mcap · 833M float · 0.323% daily turnover · Short 33% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 4Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
4
ROE
3
ROA
5
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RDY receives an overall rating of B. Strongest factors: DCF (4/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-01 B+ B
2026-07-27 C B+
2026-07-25 B+ C
2026-05-15 A- B+
2026-05-14 A A-
2026-04-21 A- A
2026-03-02 A A-
2026-02-12 A- A
2026-02-10 A A-
2026-02-09 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade B
Profitability
34
Balance Sheet
86
Earnings Quality
70
Growth
25
Value
—
Momentum
58
Safety
—
Cash Flow
59

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
3/9
✓ ✓ ✗ ✓ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
-2.58
Unlikely Manipulator
Ohlson O-Score
-11.19
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 74.3/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.32x
Accruals: -2.6%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RDY scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RDY's score of -2.58 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RDY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RDY receives an estimated rating of A (score: 74.3/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). RDY's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
30.37x
PEG
-0.73x
P/S
3.03x
P/B
2.62x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$715.34
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 30.4x earnings, RDY commands a growth premium. Graham's intrinsic value formula yields $715.34 per share, suggesting a potential 5740% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.782
NI / EBT
×
Interest Burden
0.967
EBT / EBIT
×
EBIT Margin
0.168
EBIT / Rev
×
Asset Turnover
0.636
Rev / Assets
×
Equity Multiplier
1.509
Assets / Equity
=
ROE
12.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RDY's ROE of 12.2% is driven by Asset Turnover (0.636), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$1977.71
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with RDY's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. RDY actually compounded EPS at 20.2% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. RDY trades at a premium to its adjusted intrinsic value of $1977.71, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 30.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$12.26
Median 1Y
$12.85
5th Pctile
$8.36
95th Pctile
$19.87
Ann. Volatility
26.0%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
27,527
-1.0% YoY
Revenue / Employee
$12,840,907
Rev: $353,471,642,000
Profit / Employee
$1,637,924
NI: $45,087,145,000
SGA / Employee
$4,080,974
Avg labor cost proxy
R&D / Employee
$919,608
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 2.7% 2.6% 5.3% 13.4% 7.7% 7.6% 9.4% 11.7% 21.6% 21.0% 9.6% 16.1% 15.2% 19.1% 33.4% 18.4% 17.6% 17.7% 16.4% 12.2% 12.20%
ROA 1.7% 1.7% 3.6% 8.7% 5.1% 5.2% 6.5% 8.0% 15.8% 15.3% 6.8% 11.6% 10.9% 13.1% 22.1% 12.8% 12.2% 11.6% 10.8% 8.1% 8.08%
ROIC 2.1% 2.0% 4.9% 6.7% 7.0% 7.0% 9.9% 12.4% 13.2% 13.2% 10.3% 17.7% 16.8% 17.5% 16.7% 16.6% 16.0% 15.7% 14.4% 10.7% 10.72%
ROCE 6.4% 6.2% 6.7% 8.9% 9.7% 9.7% 11.8% 13.6% 13.7% 13.2% 10.9% 18.2% 17.2% 21.7% 21.2% 21.5% 21.2% 20.3% 18.4% 14.1% 14.06%
Gross Margin 52.2% 53.4% 53.8% 52.9% 49.9% 59.1% 59.2% 57.2% 58.7% 56.4% 58.5% 58.6% 60.4% 59.6% 58.7% 55.6% 56.9% 54.7% 53.6% 44.8% 44.82%
Operating Margin 13.4% 18.0% 17.4% 16.1% 23.4% 25.1% 24.3% 20.1% 26.2% 21.1% 23.9% 21.1% 23.4% 21.9% 22.4% 20.7% 20.5% 19.9% 16.3% 0.6% 0.62%
Net Margin 11.6% 17.2% 13.3% 1.6% 22.8% 17.6% 18.4% 15.2% 20.8% 21.5% 19.1% 18.5% 18.1% 15.7% 16.9% 18.7% 16.6% 16.3% 13.9% 2.9% 2.93%
EBITDA Margin 21.4% 27.2% 24.2% 10.4% 34.6% 30.8% 29.6% 26.6% 31.5% 33.8% 31.1% 28.7% 28.4% 29.8% 29.0% 29.7% 28.8% 27.6% 22.4% 11.5% 11.47%
FCF Margin -0.1% -8.8% 3.9% 8.7% 12.9% 20.5% 24.0% 33.0% 30.1% 36.0% 20.6% 6.2% 7.3% 1.2% 0.4% 3.7% 4.3% 5.4% 7.0% 7.2% 7.20%
OCF Margin 6.0% 1.9% 18.4% 27.1% 35.8% 39.7% 39.8% 48.5% 46.4% 52.8% 34.7% 13.9% 12.1% 6.0% 7.9% 14.3% 15.7% 17.2% 18.2% 16.8% 16.77%
ROE 3Y Avg snapshot only 14.40%
ROE 5Y Avg snapshot only 12.13%
ROA 3Y Avg snapshot only 9.87%
ROIC 3Y Avg snapshot only 13.98%
ROIC Economic snapshot only 8.78%
Cash ROA snapshot only 9.96%
Cash ROIC snapshot only 15.74%
CROIC snapshot only 6.75%
NOPAT Margin snapshot only 11.42%
Pretax Margin snapshot only 16.27%
R&D / Revenue snapshot only 7.16%
SGA / Revenue snapshot only 31.07%
SBC / Revenue snapshot only 0.07%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 30.368
P/S Ratio — — — — — — — — — — — — — — — — — — — — 3.034
P/B Ratio — — — — — — — — — — — — — — — — — — — — 2.619
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
Graham Number snapshot only $715.34
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 1.73 1.90 1.99 1.93 1.98 2.19 2.30 2.38 2.60 2.59 2.55 2.58 2.55 1.92 1.92 1.92 1.89 1.85 1.88 1.80 1.802
Quick Ratio 1.18 1.32 1.40 1.39 1.41 1.58 1.72 1.81 1.95 1.91 1.90 1.92 1.90 1.36 1.37 1.37 1.36 1.35 1.38 1.35 1.345
Debt/Equity 0.19 0.16 0.15 0.18 0.12 0.08 0.08 0.06 0.05 0.05 0.07 0.07 0.10 0.16 0.16 0.14 0.14 0.16 0.18 0.21 0.205
Net Debt/Equity 0.03 0.03 -0.04 -0.06 -0.05 -0.05 -0.14 -0.21 -0.19 -0.22 -0.20 -0.22 -0.22 -0.05 -0.03 -0.03 -0.05 -0.03 -0.04 -0.03 -0.028
Debt/Assets 0.12 0.11 0.10 0.12 0.08 0.06 0.06 0.04 0.04 0.04 0.05 0.05 0.07 0.10 0.11 0.09 0.09 0.11 0.12 0.13 0.133
Debt/EBITDA 0.02 0.02 0.02 1.43 0.01 0.01 0.01 0.35 0.30 0.32 0.01 0.31 0.47 0.55 0.57 0.49 0.50 0.59 0.72 0.98 0.981
Net Debt/EBITDA 0.00 0.00 -0.00 -0.44 -0.00 -0.00 -0.01 -1.25 -1.12 -1.31 -0.01 -0.96 -0.99 -0.16 -0.09 -0.12 -0.18 -0.11 -0.16 -0.13 -0.133
Interest Coverage 17.22 17.62 18.96 18.53 22.60 21.20 23.03 22.50 32.03 30.81 33.19 39.52 39.86 41.91 34.14 35.01 26.16 24.73 22.23 15.08 15.081
Equity Multiplier 1.56 1.51 1.49 1.54 1.48 1.41 1.40 1.39 1.37 1.37 1.39 1.38 1.41 1.53 1.51 1.48 1.48 1.51 1.51 1.54 1.536
Cash Ratio snapshot only 0.524
Debt Service Coverage snapshot only 20.538
Cash to Debt snapshot only 1.135
FCF to Debt snapshot only 0.320
Defensive Interval snapshot only 528.0 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 28.23 27.81 28.62 0.70 28.53 29.16 32.20 0.40 0.81 0.78 34.34 0.60 0.59 0.74 1.28 0.74 0.72 0.68 0.66 0.64 0.636
Inventory Turnover 78.03 76.47 76.48 1.89 76.82 80.79 86.07 1.09 2.11 1.96 88.13 1.56 1.49 1.90 3.50 2.01 1.96 2.02 2.06 2.18 2.181
Receivables Turnover 138.83 124.66 132.45 3.08 122.25 114.25 138.93 1.74 3.50 3.87 152.62 2.76 2.79 3.89 6.68 3.81 3.79 3.76 3.54 3.56 3.555
Payables Turnover 147.19 143.54 151.08 6.04 146.52 164.67 168.99 3.22 4.01 3.65 169.85 4.44 2.91 3.68 6.96 6.50 3.96 3.92 4.04 6.03 6.034
DSO 3 3 3 118 3 3 3 209 104 94 2 132 131 94 55 96 96 97 103 103 102.7 days
DIO 5 5 5 193 5 5 4 334 173 186 4 234 245 192 104 182 186 181 177 167 167.4 days
DPO 2 3 2 60 2 2 2 113 91 100 2 82 125 99 52 56 92 93 90 60 60.5 days
Cash Conversion Cycle 5 5 5 251 5 5 5 430 186 180 4 284 251 187 106 221 190 185 190 210 209.5 days
Fixed Asset Turnover snapshot only 2.967
Operating Cycle snapshot only 270.0 days
Cash Velocity snapshot only 3.916
Capital Intensity snapshot only 1.685
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue -27.2% 11.3% -25.0% 9.6% 7.1% 7.0% 16.9% 16.9% 27.9% 27.9% 16.3% 74.0% 61.4% 1.2% 1.2% 54.1% 51.6% 14.1% 11.1% 3.6% 3.55%
Net Income -75.0% -54.7% -5.7% 1.1% 2.2% 2.1% 89.1% 90.4% 40.2% 40.3% 14.7% 66.9% 53.1% 99.1% 91.0% 37.7% 38.7% 9.9% 5.4% -24.2% -24.16%
EPS -75.1% -54.7% -5.6% 1.1% 2.1% 2.1% 89.0% 90.2% 40.0% 40.0% 14.5% 66.6% 52.9% 98.9% 90.9% 37.6% 38.8% 10.1% 5.6% -24.2% -24.21%
FCF -1.0% -1.4% -73.9% -42.4% 190.4% 3.5% 6.1% 3.4% 2.0% 1.2% -0.6% -67.1% -60.8% -92.8% -95.3% -8.5% -10.5% 4.2% 16.9% 1.0% 1.02%
EBITDA -34.2% -1.6% -30.3% -0.6% 40.6% 40.4% 61.6% 62.5% 33.5% 33.4% 14.9% 66.7% 55.4% 1.1% 1.0% 48.2% 51.4% 11.4% 3.9% -18.8% -18.84%
Op. Income -59.2% -39.4% -5.6% 53.0% 1.4% 1.4% 80.1% 80.1% 58.6% 58.0% 21.7% 72.6% 46.2% 96.9% 96.3% 43.6% 41.9% 5.4% -3.3% -30.8% -30.82%
OCF Growth snapshot only 21.80%
Asset Growth snapshot only 15.19%
Equity Growth snapshot only 10.86%
Debt Growth snapshot only 62.10%
Shares Change snapshot only 0.06%
Dividend Growth snapshot only -0.72%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y -11.9% -12.4% -11.4% -12.3% -11.7% -13.5% -1.6% -2.6% -0.1% 15.0% 0.6% 30.6% 30.3% 44.2% 44.2% 46.3% 46.3% 47.4% 41.8% 40.6% 40.55%
Revenue 5Y -7.8% -7.2% -6.2% -5.9% -5.5% -5.4% -3.1% -3.1% -1.3% -1.7% -1.1% 6.5% 7.3% 12.7% 19.6% 19.9% 19.5% 30.7% 20.1% 28.9% 28.89%
EPS 3Y -24.0% -27.5% -9.5% -11.8% -3.0% -10.7% 3.8% -0.8% 3.2% 25.7% 26.9% 88.2% 88.9% 1.1% 60.4% 63.4% 43.8% 45.3% 32.1% 20.2% 20.24%
EPS 5Y -16.2% -10.8% 6.0% 1.4% 10.9% 11.1% 19.8% 20.2% 14.1% 10.8% 9.9% 16.8% 14.3% 14.7% 19.6% 17.5% 18.5% 34.2% 32.7% 47.4% 47.37%
Net Income 3Y -24.0% -27.5% -9.5% -11.7% -2.9% -10.6% 3.9% -0.7% 3.3% 25.8% 27.0% 88.4% 89.1% 1.1% 60.6% 63.6% 43.8% 45.3% 32.2% 20.3% 20.35%
Net Income 5Y -16.6% -10.7% 6.0% 1.4% 10.9% 11.1% 19.8% 20.2% 14.2% 10.9% 10.0% 16.9% 14.4% 14.8% 19.7% 17.6% 18.5% 34.2% 32.7% 47.5% 47.50%
EBITDA 3Y -7.6% -9.8% -9.0% -11.6% -6.7% -8.5% 6.7% 4.8% 7.3% 22.6% 9.0% 39.1% 42.8% 58.3% 56.0% 58.9% 46.4% 46.6% 34.7% 26.1% 26.10%
EBITDA 5Y -8.2% -4.9% -2.6% -1.3% 4.9% 4.5% 9.4% 10.3% 8.2% 6.5% 6.9% 13.3% 11.0% 16.7% 23.4% 23.2% 23.8% 34.2% 22.4% 26.5% 26.49%
Gross Profit 3Y -12.8% -13.5% -12.2% -12.9% -12.4% -14.7% -0.9% -1.7% 2.2% 18.7% 3.6% 33.5% 35.1% 49.7% 49.7% 51.2% 51.5% 51.6% 41.8% 38.4% 38.44%
Gross Profit 5Y -9.6% -8.6% -7.5% -6.8% -6.4% -6.1% -2.4% -2.6% 0.2% -0.3% 0.3% 8.2% 9.6% 14.8% 21.8% 22.0% 20.6% 32.0% 20.7% 27.9% 27.89%
Op. Income 3Y -17.8% -19.7% -4.0% -8.3% -3.4% -6.2% 11.8% 9.7% 15.9% 32.1% 27.4% 68.2% 77.4% 95.6% 62.6% 64.6% 48.7% 48.6% 32.2% 19.7% 19.68%
Op. Income 5Y -17.1% -12.1% 0.8% 3.6% 11.2% 10.5% 18.5% 19.5% 16.2% 14.5% 14.1% 19.1% 15.9% 20.8% 27.3% 26.7% 26.4% 36.7% 31.5% 36.4% 36.41%
FCF 3Y — — -41.1% -24.7% -28.0% -16.3% 0.6% 19.8% 19.8% 31.5% 22.9% -5.8% — — -30.8% 9.9% 1.5% -5.5% -6.0% -15.4% -15.36%
FCF 5Y — — — — — 29.6% 29.5% 41.8% 54.3% 38.7% 7.8% -9.1% -15.3% -37.5% -45.7% -12.4% -9.6% -3.1% 9.2% 9.0% 9.04%
OCF 3Y -26.2% -53.8% -11.7% -0.7% -4.3% -0.4% 12.4% 29.2% 30.7% 37.8% 34.2% 12.9% 64.1% 1.1% 8.7% 18.2% 11.2% 11.5% 9.3% -1.3% -1.33%
OCF 5Y -30.7% -42.2% -3.0% 5.5% 21.4% 18.1% 18.4% 26.7% 33.5% 30.6% 12.0% 0.5% -9.4% -16.0% -6.3% 11.2% 13.1% 16.4% 25.5% 22.6% 22.64%
Assets 3Y -74.7% -74.8% -74.4% 9.1% -74.5% -75.2% 7.0% 3.7% 3.7% 3.7% 9.1% 3.7% 3.8% 4.0% 4.0% 19.0% 4.2% 4.3% 4.3% 20.8% 20.84%
Assets 5Y -54.7% -55.7% -55.9% 5.9% -55.6% -56.2% -56.0% 7.4% 7.7% 8.2% -54.4% 11.4% 12.8% 14.8% 1.8% 1.8% 1.7% 1.8% 1.8% 1.7% 1.75%
Equity 3Y -73.6% -73.4% -73.4% 10.8% -74.1% -74.6% 8.5% 3.8% 3.9% 3.8% 11.6% 3.9% 4.0% 4.0% 4.0% 20.5% 4.2% 4.2% 4.2% 17.0% 16.96%
Book Value 3Y -73.6% -73.4% -73.4% 10.7% -74.1% -74.6% 8.4% 3.8% 3.9% 3.8% 11.5% 3.9% 4.0% 4.0% 4.0% 20.4% 4.2% 4.2% 4.2% 16.9% 16.86%
Dividend 3Y 1.9% -0.0% -0.0% -0.1% -0.1% 6.2% 6.2% 6.2% 6.2% 10.0% 10.0% 10.0% 10.0% -0.0% -0.0% -0.0% 0.0% -0.1% -0.1% -0.3% -0.31%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.50 0.43 0.52 0.60 0.58 0.41 0.47 0.38 0.20 0.04 0.13 0.12 0.18 0.23 0.45 0.59 0.61 0.79 0.67 0.89 0.886
Earnings Stability 0.00 0.00 0.14 0.00 0.02 0.00 0.24 0.06 0.09 0.03 0.28 0.27 0.32 0.37 0.59 0.63 0.69 0.86 0.90 0.83 0.833
Margin Stability 0.96 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.95 0.95 0.96 0.96 0.94 0.94 0.95 0.95 0.95 0.94 0.96 0.95 0.955
Rev. Growth Consistency 0.00 0.50 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.98 0.50 0.50 0.50 0.50 0.50 0.84 0.84 0.94 0.50 0.50 0.50 0.50 0.85 0.85 0.96 0.98 0.90 0.903
Earnings Smoothness 0.00 0.25 0.94 0.29 0.00 0.00 0.38 0.38 0.67 0.66 0.86 0.50 0.58 0.34 0.37 0.68 0.68 0.91 0.95 0.73 0.725
ROE Trend -3.21 -0.63 -3.13 -7.36 0.59 3.30 3.70 -1.23 -4.92 -4.89 1.60 0.06 -3.68 -3.64 -8.80 0.04 0.04 0.02 -4.30 -0.04 -0.042
Gross Margin Trend -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 0.02 0.01 0.07 0.06 0.04 0.04 0.04 0.04 0.02 0.02 -0.01 -0.03 -0.04 -0.06 -0.058
FCF Margin Trend -0.21 -0.32 -0.13 -0.08 0.04 0.13 0.16 0.20 0.24 0.30 0.07 -0.15 -0.14 -0.27 -0.22 -0.16 -0.14 -0.13 -0.03 0.02 0.022
Sustainable Growth Rate 84.2% 82.3% 3.6% 9.1% 6.1% 5.6% 7.5% 9.3% 17.6% 15.8% 7.3% 13.5% 12.7% 16.7% 29.3% 16.2% 15.6% 15.7% 14.5% 10.3% 10.32%
Internal Growth Rate 1.2% 1.2% -1.7% 6.3% -1.3% -1.4% -1.2% 6.8% 14.7% 13.0% -1.2% 10.7% 10.1% 13.0% 24.0% 12.8% 12.0% 11.5% 10.6% 7.3% 7.34%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.99 0.31 1.48 2.18 2.00 2.22 1.97 2.39 2.37 2.69 1.74 0.72 0.65 0.34 0.46 0.82 0.93 1.00 1.12 1.32 1.319
FCF/OCF -0.01 -4.68 0.21 0.32 0.36 0.52 0.60 0.68 0.65 0.68 0.59 0.45 0.61 0.20 0.06 0.26 0.27 0.31 0.38 0.43 0.429
FCF/Net Income snapshot only 0.566
OCF/EBITDA snapshot only 0.732
CapEx/Revenue 6.1% 10.6% 14.5% 18.3% 22.8% 19.2% 15.8% 15.5% 16.4% 16.8% 14.1% 7.7% 4.7% 4.8% 7.5% 10.6% 11.4% 11.8% 11.2% 9.6% 9.58%
CapEx/Depreciation snapshot only 1.573
Accruals Ratio 0.01 1.17 -1.71 -0.10 -5.11 -6.36 -6.32 -0.11 -0.22 -0.26 -5.06 0.03 0.04 0.09 0.12 0.02 0.01 -0.00 -0.01 -0.03 -0.026
Sloan Accruals snapshot only -0.016
Cash Flow Adequacy snapshot only 1.453
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 0.66%
Dividend/Share $4.99 $4.99 $4.99 $4.98 $4.99 $5.99 $5.98 $5.98 $5.98 $7.98 $7.97 $7.97 $7.97 $7.99 $7.99 $7.99 $8.00 $7.99 $7.99 $7.93 $8.00
Payout Ratio 68.5% 68.1% 32.0% 32.1% 21.7% 26.1% 20.3% 20.2% 18.6% 24.8% 23.6% 16.2% 16.2% 12.5% 12.4% 11.8% 11.7% 11.4% 11.8% 15.4% 15.43%
FCF Payout Ratio — — 1.0% 45.8% 30.0% 22.8% 17.1% 12.4% 12.1% 13.5% 22.9% 50.6% 41.2% 1.9% 4.9% 55.4% 46.1% 36.1% 27.5% 27.3% 27.28%
Total Payout Ratio 71.8% 68.3% 32.1% 32.1% 21.7% 26.1% 20.3% 20.2% 18.6% 24.8% 23.6% 16.2% 16.2% 12.5% 12.4% 14.2% 14.2% 13.7% 14.2% 15.4% 15.43%
Div. Increase Streak 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.58 0.58 0.75 0.75 0.78 0.78 0.78 0.78 0.76 0.76 0.76 0.78 0.77 0.74 0.74 0.74 0.74 0.77 0.78 0.78 0.782
Interest Burden (EBT/EBIT) 0.65 0.65 0.98 0.98 0.98 0.98 0.98 0.98 1.01 1.01 1.01 1.00 1.00 0.99 0.98 0.98 0.96 0.96 0.98 0.97 0.967
EBIT Margin 0.16 0.16 0.17 0.17 0.24 0.24 0.26 0.26 0.25 0.25 0.26 0.25 0.24 0.24 0.24 0.24 0.24 0.23 0.21 0.17 0.168
Asset Turnover 28.23 27.81 28.62 0.70 28.53 29.16 32.20 0.40 0.81 0.78 34.34 0.60 0.59 0.74 1.28 0.74 0.72 0.68 0.66 0.64 0.636
Equity Multiplier 1.56 1.52 1.49 1.54 1.52 1.46 1.44 1.46 1.37 1.37 1.40 1.39 1.39 1.46 1.51 1.43 1.45 1.52 1.51 1.51 1.509
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $7.29 $7.32 $15.58 $15.53 $22.95 $22.95 $29.45 $29.55 $32.13 $32.14 $33.71 $49.24 $49.11 $63.94 $64.34 $67.77 $68.19 $70.37 $67.91 $51.37 $51.37
Book Value/Share $2.88 $2.98 $3.07 $229.07 $3.05 $3.05 $3.20 $277.42 $294.56 $303.63 $3.86 $336.41 $353.30 $366.07 $380.82 $399.60 $420.23 $430.35 $446.91 $442.74 $464.45
Tangible Book/Share $2.24 $2.38 $2.48 $191.00 $2.50 $2.51 $2.69 $235.27 $243.75 $254.11 $3.27 $287.00 $303.69 $241.52 $255.23 $269.42 $291.09 $294.41 $309.22 $304.24 $304.24
Revenue/Share $120.08 $120.16 $124.85 $124.91 $128.48 $128.47 $145.88 $145.81 $164.10 $163.98 $169.25 $253.25 $264.45 $359.50 $373.13 $390.19 $401.26 $410.73 $415.07 $403.81 $397.74
FCF/Share $-0.09 $-10.53 $4.91 $10.89 $16.60 $26.29 $35.06 $48.05 $49.39 $58.98 $34.78 $15.76 $19.35 $4.27 $1.62 $14.42 $17.33 $22.17 $29.11 $29.06 $17.66
OCF/Share $7.24 $2.25 $23.02 $33.79 $45.95 $50.96 $58.07 $70.71 $76.22 $86.52 $58.65 $35.21 $31.91 $21.58 $29.45 $55.65 $63.10 $70.61 $75.74 $67.74 $47.78
Cash/Share $0.46 $0.40 $0.57 $53.34 $0.53 $0.41 $0.70 $74.22 $70.92 $81.32 $1.05 $97.69 $113.47 $75.62 $70.93 $69.41 $80.06 $83.80 $99.12 $103.11 $97.79
EBITDA/Share $26.74 $26.79 $28.58 $28.51 $37.56 $37.59 $46.16 $46.28 $50.07 $50.06 $52.90 $77.02 $77.68 $105.98 $108.18 $114.11 $117.75 $118.24 $112.55 $92.56 $92.56
Debt/Share $0.54 $0.49 $0.46 $40.69 $0.38 $0.26 $0.26 $16.18 $15.04 $15.87 $0.29 $24.01 $36.78 $58.19 $61.23 $56.05 $58.39 $70.27 $81.29 $90.81 $90.81
Net Debt/Share $0.08 $0.09 $-0.11 $-12.65 $-0.15 $-0.15 $-0.45 $-58.04 $-55.88 $-65.45 $-0.76 $-73.69 $-76.69 $-17.42 $-9.70 $-13.35 $-21.66 $-13.53 $-17.83 $-12.30 $-12.30
Per Employee
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Employee Count snapshot only 27,527
Revenue/Employee snapshot only $12246245.21
Income/Employee snapshot only $1557861.15
EBITDA/Employee snapshot only $2806995.82
FCF/Employee snapshot only $881206.89
Assets/Employee snapshot only $20629800.12
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 4 6 5 4 7 8 8 8 6 5 7 6 5 5 3 4 5 6 5 3 3
Beneish M-Score -2.15 2.97 -10.01 75.27 -26.28 -33.04 -32.30 -2.97 53.20 75.98 -24.06 78.43 -2.25 82.31 84.57 -1.81 -1.65 -2.25 -2.37 -2.58 -2.582
Ohlson O-Score snapshot only -11.193
ROIC (Greenblatt) snapshot only 23.12%
Net-Net WC snapshot only $121.04
EVA snapshot only $2576531328.70
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only A
Credit Score 70.66 71.07 78.78 74.08 80.63 80.81 81.78 80.07 80.42 80.13 80.42 79.99 80.40 73.31 72.89 76.24 75.79 76.34 76.53 74.29 74.287
Credit Grade snapshot only 6
Credit Trend snapshot only -1.952
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 73

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms